Scientists have developed a gel-based version of semaglutide that could reduce how often people need to take it.

Prescriptions for the weight-loss blockbuster drugs Ozempic and Wegovy have soared ... Wegovy (also semaglutide), saw sales soar soon after its launch as well. According to researchers led by ...

GLP-1 drugs like Ozempic and Wegovy may help reduce risks from severe COVID-19 for people living with overweight or obesity, ...

Popular drugs include Ozempic and Wegovy from Novo Nordisk, and Mounjaro from Eli Lilly. They have helped obese patients lose more than 20% of their body weight by producing proteins that stimulate ...

A woman who used the semaglutide drugs Wegovy and Ozempic to lose weight and treat diabetes says the drugmaker didn't ...

“I do worry about what’s going to happen in a month.” Sponsor Message The massive popularity of Ozempic, Wegovy, Mounjaro and Zepbound has meant the drugs have been in and out of short supply for more ...

Weight loss drugs have gone viral. But despite their availability, most people who could benefit from treatments can't access ...

Weight-loss drugs such as Ozempic come with a risk of severe side effects. The viral weight-loss drug semaglutide, which is ...

Ozempic, Wegovy, Mounjaro and other weight loss drugs work by boosting metabolism and suppressing appetite, a new trial suggests.

Plus: GLP-1 drugs like Ozempic have potential to treat cancer, COVID-19, heart disease, and many other diseases.